SKI Market

A+| A| A-|

Indian Indices

Sensex

77,569.39 827.57
( 1.08%)

Global Indices

Nasdaq

52,658.24 149.83
(0.29%)

Dow Jones

7,594.79 30.15
(0.40%)

Hang Seng

68,634.11 890.26
(1.31%)

Nikkei 225

10,498.02 25.57
(0.24%)

Forex

USD-INR

95.45 -0.01
(-0.01%)

EUR-INR

109.10 0.17
(0.15%)

GBP-INR

127.94 0.35
(0.28%)

JPY-INR

0.59 0.00
(0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

132.2958859

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

45.45

41258.84

EPS(TTM)

Face Value()

Div & Yield %

53.59

2.34

Back

sri rpp infra projects ltd

Dishman Carbogen Amcis reports consolidated net loss of Rs 12.97 crore in the December 2025 quarter

Feb 04,2026

Net loss of Dishman Carbogen Amcis reported to Rs 12.97 crore in the quarter ended December 2025 as against net profit of Rs 4.63 crore during the previous quarter ended December 2024. Sales rose 5.49% to Rs 719.80 crore in the quarter ended December 2025 as against Rs 682.34 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	719.80	682.34	5
OPM %	15.71	20.54	-
PBDT	73.98	96.98	-24
PBT	-10.44	25.01	PL
NP	-12.97	4.63	PL

77,569.39 827.57 ( 1.08%)

52,658.24 149.83 (0.29%)

7,594.79 30.15 (0.40%)

68,634.11 890.26 (1.31%)

10,498.02 25.57 (0.24%)

95.45 -0.01 (-0.01%)

109.10 0.17 (0.15%)

127.94 0.35 (0.28%)

0.59 0.00 (0.03%)